Multicenter phase II trial of adjuvant therapy for resected pancreatic cancer using cisplatin, 5-fluorouracil, and interferon-alfa-2b-based chemoradiation: ACOSOG Trial Z05031 Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Pancreatic Neoplasms

abstract

  • Notwithstanding promising multi-institutional efficacy results, further development of this regimen will require additional modifications to mitigate toxic effects.

publication date

  • February 2, 2011

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3030467

Digital Object Identifier (DOI)

  • 10.1093/annonc/mdq384

PubMed ID

  • 20670978

Additional Document Info

start page

  • 348

end page

  • 54

volume

  • 22

number

  • 2